Cleared Special

MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P (K120430) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K120430 · Microlife Intellectual Property GmbH · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
171d
Days
Class 2
Risk

K120430 is an FDA 510(k) clearance for the MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Microlife Intellectual Property GmbH (Great Neck, US). The FDA issued a Cleared decision on August 2, 2012 after a review of 171 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Microlife Intellectual Property GmbH devices

Submission Details

510(k) Number K120430 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2012
Decision Date August 02, 2012
Days to Decision 171 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d slower than avg
Panel avg: 125d · This submission: 171d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 270
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K120430.
EV1000 Clinical Platform with ClearSight Finger Cuff or ClearSight System, EV1000 Clinical Platform
K160552 · Edwards Lifesciences, LLC · Jun 2016
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
NEXFIN MODEL 2
K122381 · Edwards Lifesciences, LLC · Apr 2013
U-RIGHT TD-3124 BLOOD PRESSURE MONITORING SYSTEM
K120634 · Taidoc Technology Corporation · Jul 2012
U-RIGHT TD-3128 BLOOD PRESSURE MONITORING SYSTEM
K112216 · Taidoc Technology Corporation · Dec 2011
U-RIGHT TD-3135 BLOOD PRESSURE MONITORING SYSTEM
K112274 · Taidoc Technology Corporation · Dec 2011